Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
JCO Precision Oncology|May 31, 2024
Exceptional Response of <i>BRAF</i><sup>V600E</sup>-Mutated Acinar Cell CUP to BRAF/MEK InhibitionIrina A Kerle, Anne-Marie Scheuble, Benjamin Kobitzsch, et al.
International Journal of Cancer|September 19, 2020
Integrating proteomics into precision oncologyLeonie W Wahjudi, Stephan Bernhardt, Khalid Abnaof, et al.
The Oncologist|August 28, 2020
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case SeriesJacques Cadranel, Stephen V Liu, Michaël Duruisseaux, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplificationStefan Gröschel, Martin Bommer, Barbara Hutter, et al.
Cancer Treatment and Research Communications|September 11, 2025
Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trialChristoph E Heilig, Christoph Heining, Editha Gnutzmann, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Response to olaparib in a <i>PALB2</i> germline mutated prostate cancer and genetic events associated with resistancePeter Horak, Joachim Weischenfeldt, Gunhild von Amsberg, et al.
Oncogene|September 28, 2019
Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domainsFlorian Weinberg, Ricarda Griffin, Martina Fröhlich, et al.
Nature Communications|January 19, 2026
The Knowledge Connector decision support system for multiomics-based precision oncologyDaniel Hübschmann, Simon Kreutzfeldt, Benjamin Roth, et al.
Cell Reports. Medicine|September 21, 2023
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivityAlexander A Wurm, Silke Brilloff, Sofia Kolovich, et al.
Nature Communications|June 12, 2025
A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancerErika Zuljan, Benjamin von der Emde, Iris Piwonski, et al.
Pageof 4